(2) There was a significant (p = 0.002) difference in changes in C5a levels between pneumonia (non-COVID-19) patients and ARDS (COVID-19) patients for the passage of time mentioned above, with a large effect size (d = 1.01). This evidence concerns the gene C5 and acute respiratory distress syndrome.